Virax Biolabs Group Limited () Press Releases https://ir.viraxbiolabs.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png Virax Biolabs Group Limited Logo Equisolve Investor Relations Suite <![CDATA[Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/79/virax-biolabs-achieves-iso-certifications-laying Tue, 31 Mar 26 07:34:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/79/virax-biolabs-achieves-iso-certifications-laying <![CDATA[Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/78/virax-biolabs-group-limited-announces-closing-of-5-million Thu, 04 Dec 25 16:05:00 -0500 https://ir.viraxbiolabs.com/news-events/press-releases/detail/78/virax-biolabs-group-limited-announces-closing-of-5-million <![CDATA[Virax Biolabs Group Limited Announces $5 Million Private Placement]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/77/virax-biolabs-group-limited-announces-5-million-private Wed, 03 Dec 25 13:53:00 -0500 https://ir.viraxbiolabs.com/news-events/press-releases/detail/77/virax-biolabs-group-limited-announces-5-million-private <![CDATA[Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/76/virax-biolabs-ceo-james-foster-outlines-clinical-progress Wed, 03 Dec 25 07:34:00 -0500 https://ir.viraxbiolabs.com/news-events/press-releases/detail/76/virax-biolabs-ceo-james-foster-outlines-clinical-progress <![CDATA[Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/75/virax-biolabs-completes-uk-clinical-recruitment-and-reports Mon, 03 Nov 25 08:29:00 -0500 https://ir.viraxbiolabs.com/news-events/press-releases/detail/75/virax-biolabs-completes-uk-clinical-recruitment-and-reports <![CDATA[Virax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/74/virax-biolabs-partners-with-emory-university-on Tue, 26 Aug 25 07:30:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/74/virax-biolabs-partners-with-emory-university-on <![CDATA[Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/73/virax-biolabs-appoints-iain-miller-phd-as-independent Tue, 29 Jul 25 07:35:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/73/virax-biolabs-appoints-iain-miller-phd-as-independent <![CDATA[Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/72/virax-biolabs-announces-receipt-of-nasdaq-notification Fri, 18 Jul 25 16:15:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/72/virax-biolabs-announces-receipt-of-nasdaq-notification <![CDATA[Virax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection Syndromes]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/71/virax-biolabs-enrolls-first-patients-in-clinical-study Tue, 18 Mar 25 07:30:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/71/virax-biolabs-enrolls-first-patients-in-clinical-study <![CDATA[Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting]]> https://ir.viraxbiolabs.com/news-events/press-releases/detail/70/virax-biolabs-presents-data-on-t-cell-dysfunction-in Thu, 13 Mar 25 07:30:00 -0400 https://ir.viraxbiolabs.com/news-events/press-releases/detail/70/virax-biolabs-presents-data-on-t-cell-dysfunction-in